0000908662-15-000277.txt : 20150805
0000908662-15-000277.hdr.sgml : 20150805
20150805172315
ACCESSION NUMBER: 0000908662-15-000277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150803
FILED AS OF DATE: 20150805
DATE AS OF CHANGE: 20150805
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYAX CORP
CENTRAL INDEX KEY: 0000907562
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043053198
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
BUSINESS PHONE: 617-250-5769
MAIL ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTAGE INC
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christensen Gustav
CENTRAL INDEX KEY: 0001397709
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24537
FILM NUMBER: 151030043
MAIL ADDRESS:
STREET 1: DYAX CORP.
STREET 2: 300 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-08-03
0000907562
DYAX CORP
DYAX
0001397709
Christensen Gustav
C/O DYAX CORP.
55 NETWORK DRIVE
BURLINGTON
MA
01803-2756
1
1
0
0
CEO and President
Common Stock
2015-08-03
4
M
0
76045
1.91
A
288545
D
Common Stock
2015-08-03
4
G
0
50000
0
D
238545
D
Common Stock
2015-08-03
4
M
0
250000
2.09
A
488545
D
Common Stock
2015-08-03
4
S
0
86315
24.1876
D
402230
D
Common Stock
2015-08-03
4
M
0
67967
3.00
A
470197
D
Common Stock
2015-08-04
4
S
0
70090
23.8671
D
400107
D
Common Stock
2015-08-05
4
S
0
93595
23.5409
D
306512
D
Stock Option (right to buy)
1.91
2015-08-03
4
M
0
76045
0
D
2021-02-10
Common Stock
76045
523955
D
Stock Option (right to buy)
2.09
2015-08-03
4
M
0
250000
0
D
2019-05-14
Common Stock
250000
0
D
Stock Option (right to buy)
3.00
2015-08-03
4
M
0
67967
0
D
2023-02-07
Common Stock
67967
332033
D
The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.59 to $24.46, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.
The options were fully exercisable as of February 10, 2015.
The options were fully exercisable as of May 14, 2013.
/s/ Andrew D. Ashe as attorney-in-fact
2015-08-05